Sign Up Today and Learn More About Renibus Therapeutics Stock
Invest in or calculate the value of your shares in Renibus Therapeutics or other pre-IPO companies through EquityZen's platform.
Renibus Therapeutics Stock (RENT)
Renibus Therapeutics is a clinical-stage biotech company that focuses on preventing and treating kidney disease.
About Renibus Therapeutics Stock
Founded
2016
Headquarters
Southlake, TX, US
Industries
Science and Engineering, Health Care, Biotechnology
Renibus Therapeutics Press Mentions
Stay in the know about the latest news on Renibus Therapeutics
Renibus Therapeutics Announces Oral Presentation on RBT-1 at the European Association for Cardio-Thoracic ...
prnewswire • May 23, 2024
Renibus Announces Leadership Transition
prnewswire • May 23, 2024
Renibus Therapeutics to Present at the Evercore ISI 2024 Emerging Biotech Conference
prnewswire • May 23, 2024
Renibus Therapeutics Announces Oral Presentations on RBT-1 at AATS and SCA Medical Conferences
prnewswire • May 23, 2024
Stress test and treatment of chronic kidney disease
patents • Apr 15, 2024
Renibus Therapeutics Management
Leadership team at Renibus Therapeutics
Co-Founder and Co-CEO
D. Jeffrey Keyser
Chairman
Alvaro Guillem
Join now and verify your accreditation status to gain access to:
- Renibus Therapeutics current valuation
- Renibus Therapeutics stock price
- Available deals in Renibus Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Renibus Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Renibus Therapeutics through EquityZen funds. These investments are made available by existing Renibus Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Renibus Therapeutics stock?
Shareholders can sell their Renibus Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
